Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain (DARIOS)

AstraZeneca

Status: Completed

Conditions: Atherosclerosis Risk; Inflammatory and Oxidative Status in the Spanish Population; Increased hsCRP; Dyslipaemia

Study type: Observational

Funder types: Industry

Identifiers

NCT00998062

NIS-CES-DUM-2009/1

Details and patient eligibility

About

The present project is aimed at determining the prevalence of LDL-C <130 mg/dl with hsCRP ≥2mg/l, and of HDL-C < 40 mg/dl in Spain together with the estimation of cardiovascular risk, to analyze the contribution of measuring hsCRP for primary prevention purposes. In a subgroup of that population a number of inflammatory and oxidative status biomarkers would be also measured to better understand the meaning of elevated hsCRP.The study aim to analyze data already collected in studies (11 studies will participate) carried out in Spain, in 10 Spanish regions, after the year 2000.

Enrollment: 30,181 estimated patients

Sex: All

Ages: 35 to 74 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have an Informed consent form signed when the patient accepted to participate in the study already performed.
• Spanish population between
• Data from Epidemiological studies performed after the year 2000

Exclusion criteria

• Spanish population outside the age range
• Data from Epidemiological studies performed before the year 2000

Trial design

30,181 participants in 1 patient group

1

Description:

Data from epidemiological studies performed after the year 2000 with patients between 35 and 74 years old